Advertisement

PRF Technologies Ltd. PRFX

Set alert

Price alert · PRFX

All alert types
0.73 USD -0.02 -2.68%

At close · Oct 30

0.80 +0.07 +9.57%

After hours · Oct 30, 7:42 PM ET

Bid
0.73 × 2
Ask
0.75 × 2
0.71 Day range 0.7421
0.712 52-week range 6.20
YTD
-77.26%
1 year
-87.83%
Open
0.7271
Prev close
0.7502
Mkt cap
2.55M
Vol
58.59K
Avg vol
260.32K
EPS
-4.09
P/E
0.00
Div yield
0.00%
More statistics
Low
0.71
High
0.7421
Forward P/E
-0.37
Beta
0.56
Short ratio
0.02
Inst. own
6.57%
Dividend
0.00
Ex-div date
Earnings
Feb 29, 2024
50-d avg
1.84
200-d avg
3.57
1y target
0.00

2Y chart

Chart tools
Interval

Events in this range
  • Nov 21, 2024Split: 1 for 4
  • Feb 6, 2026Split: 1 for 5
Signals (79)
NameDateAgo
MACD: Buy SignalOct 28, 20264 days ago
RSI: OversoldOct 19, 20261 week ago
MACD: Sell SignalOct 5, 20263 weeks ago
MACD: Buy SignalSep 16, 20261 month ago
MACD: Sell SignalSep 14, 20261 month ago
MACD: Buy SignalAug 4, 20262 months ago
MACD: Sell SignalJun 23, 20264 months ago
SMA: BearishJun 16, 20264 months ago
SMA: BullishJun 15, 20264 months ago
MACD: Buy SignalJun 15, 20264 months ago
MACD: Sell SignalJun 9, 20264 months ago
SMA: BearishJun 1, 20265 months ago
SMA: BullishMay 29, 20265 months ago
MACD: Buy SignalMay 29, 20265 months ago
RSI: OverboughtMay 29, 20265 months ago
RSI: OversoldMay 26, 20265 months ago
RSI: OversoldMay 21, 20265 months ago
RSI: OversoldMay 12, 20265 months ago
MACD: Sell SignalApr 27, 20266 months ago
SMA: BearishApr 20, 20266 months ago
SMA: BullishApr 17, 20266 months ago
SMA: BearishApr 15, 20266 months ago
SMA: BullishApr 13, 20266 months ago
MACD: Buy SignalApr 2, 20267 months ago
RSI: OversoldMar 30, 20267 months ago
MACD: Sell SignalMar 17, 20267 months ago
MACD: Buy SignalMar 11, 20267 months ago
MACD: Sell SignalMar 5, 20268 months ago
MACD: Buy SignalFeb 18, 20268 months ago
MACD: Sell SignalJan 27, 20269 months ago
SMA: BearishJan 23, 20269 months ago
SMA: BullishJan 16, 20269 months ago
MACD: Buy SignalJan 8, 20269 months ago
RSI: OversoldDec 30, 202510 months ago
MACD: Sell SignalDec 24, 202510 months ago
MACD: Buy SignalNov 25, 202511 months ago
RSI: OversoldNov 11, 202511 months ago
MACD: Sell SignalOct 30, 20251 year ago
MACD: Buy SignalOct 27, 20251 year ago
MACD: Sell SignalOct 10, 20251 year ago
SMA: BearishOct 9, 20251 year ago
SMA: BullishOct 8, 20251 year ago
MACD: Buy SignalOct 8, 20251 year ago
MACD: Sell SignalOct 1, 20251 year ago
SMA: BearishSep 25, 20251 year ago
SMA: BullishSep 23, 20251 year ago
SMA: BearishSep 22, 20251 year ago
MACD: Buy SignalSep 22, 20251 year ago
SMA: BullishSep 19, 20251 year ago
SMA: BearishSep 5, 20251 year ago
SMA: BullishSep 4, 20251 year ago
MACD: Sell SignalAug 29, 20251 year ago
SMA: BearishAug 28, 20251 year ago
SMA: BullishAug 19, 20251 year ago
RSI: OverboughtAug 19, 20251 year ago
MACD: Buy SignalAug 11, 20251 year ago
MACD: Sell SignalAug 5, 20251 year ago
MACD: Buy SignalJul 9, 20251 year ago
RSI: OversoldJun 23, 20251 year ago
MACD: Sell SignalJun 16, 20251 year ago
SMA: BearishJun 5, 20251 year ago
SMA: BullishJun 4, 20251 year ago
MACD: Buy SignalMay 23, 20251 year ago
MACD: Sell SignalMay 8, 20251 year ago
MACD: Buy SignalApr 14, 20251 year ago
RSI: OversoldApr 7, 20251 year ago
RSI: OversoldMar 31, 20251 year ago
MACD: Sell SignalFeb 27, 20251 year ago
MACD: Buy SignalFeb 26, 20251 year ago
MACD: Sell SignalFeb 25, 20251 year ago
SMA: BearishFeb 21, 20251 year ago
SMA: BullishFeb 18, 20251 year ago
MACD: Buy SignalFeb 18, 20251 year ago
SMA: BearishJan 31, 20251 year ago
MACD: Sell SignalDec 26, 20241 year ago
MACD: Buy SignalDec 19, 20241 year ago
RSI: OverboughtDec 19, 20241 year ago
RSI: OverboughtDec 5, 20241 year ago
RSI: OverboughtNov 21, 20241 year ago

Key statistics

Market cap
3.90M
Enterprise value
339.62K
Trailing P/E
0.00
Forward P/E
-0.37
PEG ratio
0.00
Price / sales
0.00
Price / book
0.00
EPS (TTM)
-147.36
Beta
0.56
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-4.93M
Total cash
2.78M
Total debt
59.00K
Return on equity
-716.67%
Shares outstanding
874.86K
Short % of float
9.08%
50-day average
1.84
200-day average
3.57

Analyst view

Consensus: none

Price target (mean) 0.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
  • Strong buy0
  • Buy0
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Feb 29, 2024

Expected Feb 29, 2024. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
PRFX Revenue — quarterly 0
2021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 2024
PRFX Net income — quarterly -7.31M
2021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 2024
PRFX EPS — quarterly 10.00
2021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 2024

Earnings

PRFX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Aug 15, 2024Jun 1, 20240.00-9.60——
May 15, 2024Mar 1, 20240.00-65.27——
Feb 29, 2024Dec 1, 20230.00———
Nov 15, 2023Sep 1, 20230.0011.52——
May 15, 2023Mar 1, 20230.00-52.79——
Mar 16, 2023Dec 1, 20220.00-69.59——

Upgrades / downgrades

PRFX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 24, 2024Maxim GroupdownBuyHold
Jun 26, 2024Maxim GroupreitBuyBuy

About PRF Technologies Ltd.

PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations. The company was incorporated in 2007 and is based in Tel Aviv, Israel.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Israel

News

Your note

Sign in to keep a note on PRFX — it syncs with the Stock Master app.

Institution ownership

PRFX institution ownership
Holder% heldSharesValueReported
UBS Group AG0.74%6,49628.97KSep 29, 2024
Two Sigma Securities, LLC0.49%4,30819.21KSep 29, 2024
HRT Financial LP0.41%3,57715.95KSep 29, 2024
Osaic Holdings Inc0.02%192856Sep 29, 2024

Fund ownership

PRFX fund ownership
Holder% heldSharesValueReported
Fidelity NASDAQ Composite Index Fund0.01%80356Sep 29, 2024
Advertisement